Source Bioscience Plc
| London Stock Exchange: SBS
Similar to: EpiStem Holdings Plc
Source BioScience plc provides diagnostics and genetic analysis services and products to healthcare and life science research markets. The company operates through two segments: LifeSciences and Healthcare. The LifeSciences segment provides DNA sequencing services and related products through a network of laboratories and distributors to academic research groups, biotechnology, and pharmaceutical companies. This segment also offers GenomeCube, a proprietary search engine and bioinformatics tool; Illumina MiSeq, a sequencing platform; and reSource range of own branded products, primarily focused on the life science research work flow requirements for the DNA extraction and preparation. The Healthcare segment offers cytology and diagnostics activities, including cervical cancer screening and diagnostic testing services for diseases, such as cancer. It also offers histopathology, cellular pathology, molecular diagnostics, and companion diagnostic testing services to NHS, public, and private healthcare providers. This segment also manufactures blood banking and serology products for the NHS and biobank providers. The company provides diagnostic and genomic services; distributes diagnostic and genomic products; and engages in the property lease rentals. Source BioScience was founded on March 19, 1905 and is headquartered in Nottingham, the United Kingdom.